Figure 1From: Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder AA:EPA ratio changes from week 4 to 8 in the participants with EPA/DHA concentrate dosage changes.* * Each line represents a participant's AA:EPA ratio from week 4 to week 8 in the five who were instructed to decrease their intake of the EPA/DHA concentrate.Back to article page